|
|
Volumn 97, Issue 5, 2005, Pages 334-336
|
|
As genetic tests move into the mainstream, challenges await for doctors and patients
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APC PROTEIN;
BRCA1 PROTEIN;
BRCA2 PROTEIN;
CYCLIN DEPENDENT KINASE 4;
PROTEIN MLH1;
PROTEIN MSH2;
PROTEIN RET;
RETINOBLASTOMA PROTEIN;
SCATTER FACTOR RECEPTOR;
VON HIPPEL LINDAU PROTEIN;
CANCER;
CANCER GENETICS;
CANCER RISK;
CLINICAL PRACTICE;
FAMILIAL CANCER;
GENE MUTATION;
GENETIC COUNSELING;
GENETIC SUSCEPTIBILITY;
HEALTH CARE POLICY;
HEALTH INSURANCE;
HEALTH PROMOTION;
HUMAN;
NOTE;
ONCOGENE RET;
PRIMARY MEDICAL CARE;
PRIORITY JOURNAL;
TUMOR SUPPRESSOR GENE;
ARTICLE;
ECONOMICS;
GENETIC SCREENING;
GENETICS;
HEALTH PERSONNEL ATTITUDE;
INSURANCE;
NEOPLASM;
PHYSICIAN;
PRACTICE GUIDELINE;
STANDARD;
UNITED STATES;
ATTITUDE OF HEALTH PERSONNEL;
GENETIC COUNSELING;
GENETIC SCREENING;
HUMANS;
INSURANCE COVERAGE;
INSURANCE, HEALTH;
NEOPLASMS;
PHYSICIANS;
PRACTICE GUIDELINES;
UNITED STATES;
|
|
EID: 14544289132
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/97.5.334 Document Type: Note |
|
Times cited : (8)
|
|
References (0)
|